| Why Not Give a Vegetarian Diet a Try for the New Year?
The New Year is upon us, and at PETA, we're encouraging people to, for their new year's resolution, give a healthy vegetarian diet a try. Just last month, the Centers for Disease Control in Atlanta celebrated that the average cholesterol level in this country has fallen to 199, which is below (just barely) their stated target of 200. It's too bad the CDC is happy with a 199 average in this country, since at 199, people are still dropping like flies from heart disease. Heart disease kills more people in North America than does any other cause of death. Up until the 1980s, it was assumed that as people get older, their arteries inevitably become clogged. If you didn't get hit by a bus or die of cancer or something else, your arteries would eventually close, causing either your brain or your heart to give out, and that would be it.
Gas-burning C300 a real barnburner
One thing before reading on: Please put down the voodoo dolls and stickpins.
The vehicle tested this week gets less than 30 m.p.g. highway, has no batteries hidden under the rear seat and will cost less than $20,000 only when as used in 10 years.
It's the 2008 Mercedes-Benz C300, an entry-level sedan to invite people into the luxury segment who Mercedes hopes will stay when they can afford something at $50,000 or more.
.
Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania ...
VIENNA, Austria, Oct. 17 /PRNewswire/ -- New data show that asenapine -- a psychopharmacologic agent being developed by Organon -- is effective in treating acute manic episodes associated with bipolar I disorder. These results, from two Phase III clinical studies, were presented this week at the 20th European College of Neuropsychopharmacology (ECNP) Congress. "The results of these clinical trials add to the body of evidence supporting the clinical efficacy and safety of asenapine," said Roger S. McIntyre, M.D., Associate Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. "The complex nature of bipolar disorders suggests that we should have many treatment options available to physicians and patients.
|
